{"DataElement":{"publicId":"7378925","version":"1","preferredName":"Kaposi Sarcoma Skin Plaque Or Nodule Lesion Percentage Change Value","preferredDefinition":"Numeric value that represents the percentage change of raised Kaposi sarcoma lesions.","longName":"TRORRES_PCHG1","context":"AMC","contextVersion":"1","DataElementConcept":{"publicId":"7374898","version":"1","preferredName":"Kaposi Sarcoma Skin Plaque Or Nodule Lesion Percentage Change","preferredDefinition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS)._A large (greater than 5-10 mm) raised skin lesion with a wide, flat surface._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A small lump, swelling or collection of tissue._A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part._A fraction or ratio with 100 understood as the denominator._The act of alteration or modification; changed or altered in form or character.","longName":"7374896v1.0:5052931v1.0","context":"AMC","contextVersion":"1","ObjectClass":{"publicId":"7374896","version":"1","preferredName":"Kaposi Sarcoma Skin Plaque Or Nodule Lesion","preferredDefinition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).:A large (greater than 5-10 mm) raised skin lesion with a wide, flat surface.:An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.:A small lump, swelling or collection of tissue.:A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","longName":"7374896v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kaposi Sarcoma","conceptCode":"C9087","definition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Skin Plaque","conceptCode":"C39624","definition":"A large (greater than 5-10 mm) raised skin lesion with a wide, flat surface.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Nodule","conceptCode":"C3280","definition":"A small lump, swelling or collection of tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lesion","conceptCode":"C3824","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ABBCECAA-868D-75C1-E053-4EBD850A144A","latestVersionIndicator":"Yes","beginDate":"2020-07-31","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-31","modifiedBy":"ONEDATA","dateModified":"2020-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5052931","version":"1","preferredName":"Percentage Change","preferredDefinition":"A fraction or ratio with 100 understood as the denominator.:The act of alteration or modification; changed or altered in form or character.","longName":"C25613:C25446","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Change","conceptCode":"C25446","definition":"The act of alteration or modification; changed or altered in form or character.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"253966AA-480A-B77E-E050-BB89AD435CC1","latestVersionIndicator":"Yes","beginDate":"2015-11-23","endDate":null,"createdBy":"KARNATAA","dateCreated":"2015-11-23","modifiedBy":"ONEDATA","dateModified":"2015-11-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ABBCECAA-869B-75C1-E053-4EBD850A144A","latestVersionIndicator":"Yes","beginDate":"2020-07-31","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-07-31","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeDescription":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2903088","version":"1","preferredName":"Percentage Value","preferredDefinition":"A numerical quantity measured or assigned or computed that is a fraction or ratio with 100 understood as the denominator.","longName":"PER_VAL","context":"NCI Standards","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"%","minLength":null,"maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":"0","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2208119","version":"1","preferredName":"Percentage Value","preferredDefinition":"Percentage; a fraction or ratio with 100 understood as the denominator.:A numerical quantity measured or assigned or computed.","longName":"C25613:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3E46-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"6CB91576-373C-243B-E040-BB89AD43311A","latestVersionIndicator":"Yes","beginDate":"2009-06-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-06-19","modifiedBy":"COOPERM","dateModified":"2019-04-17","changeDescription":"10/23/18 jk chg reg status to Standard as part of RECIST FG content; reused by 30 CDEs and multiple SOs. 10-19-2018 TMT received permission from BC to transfer ownership from NIDCR to NCI Standards.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"7283431","version":"1","longName":"CRF CDEs","context":"AMC","ClassificationSchemeItems":[{"publicId":"7312662","version":"1","longName":"KS","context":"AMC"}]}],"AlternateNames":[{"name":"AMC","type":"USED_BY","context":"AMC"},{"name":"TRORRES_PCHG2","type":"OID, AMC","context":"AMC"},{"name":"TRORRES_PCHG3","type":"OID, AMC","context":"AMC"}],"ReferenceDocuments":[{"name":"Percent Change from Baseline","type":"Preferred Question Text","description":"Percent Change from Baseline","url":null,"context":"AMC"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AC126D57-D51E-5AD8-E053-4EBD850A896F","latestVersionIndicator":"Yes","beginDate":"2020-08-04","endDate":null,"createdBy":"COLLIED","dateCreated":"2020-08-04","modifiedBy":"COLLIED","dateModified":"2020-08-27","changeDescription":"Curated for AMC 107 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}